Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson's disease patients carrying the heterozygous mutations c.815G > A (p.R272Q) or c.1348C > T (p. R450C) in the RHOT1 gene encoding Miro1

被引：0

作者：

Chemla, Axel ^{[1
]}

Arena, Giuseppe ^{[1
,11
]}

Onal, Gizem ^{[2
,3
,4
]}

Walter, Jonas ^{[5
,12
]}

Berenguer-Escuder, Clara ^{[1
]}

Grossmann, Dajana ^{[1
,6
]}

Grunewald, Anne ^{[7
,8
]}

Schwamborn, Jens C.

Kruger, Rejko ^{[1
,9
,10
,11
]}

机构：

[1] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Translat Neurosci, Esch Sur Alzette, Luxembourg

[2] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England

[3] Univ Oxford, Kavli Inst Nanosci Discovery, Oxford, England

[4] Balikesir Univ, Fac Med, Dept Med Biol, Balikesir, Turkiye

[5] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Dev & Cellular Biol, Belvaux, Luxembourg

[6] Univ Rostock, Univ Med Ctr Rostock, Dept Neurol, Translat Neurodegenerat Sect Albrecht Kossel, Rostock, Germany

[7] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Mol & Funct Neurobiol, Luxembourg, Luxembourg

[8] Univ Lubeck, Inst Neurogenet, Lubeck, Germany

[9] Ctr Hospitalier Luxembourg, Luxembourg, Luxembourg

[10] Luxembourg Inst Hlth LIH, Transversal Translat Med, Luxembourg, Luxembourg

[11] Univ Luxembourg, Luxembourg Ctr Syst Biomed LCSB, Translat Neurosci Team, Campus Belval,6 Ave Swing, L-4367 Esch Sur Alzette, Luxembourg

[12] Univ Copenhagen, Novo Nord Fdn Ctr Prot Res, Fac Hlth & Med Sci, Dept Prote, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark

来源：

STEM CELL RESEARCH | 2023年 / 71卷

关键词：

D O I：

10.1016/j.scr.2023.103145

中图分类号：

Q813 [细胞工程];

学科分类号：

摘要：

Fibroblasts from two Parkinson's disease (PD) patients carrying either the heterozygous mutation c.815G > A (Miro1 p.R272Q) or c.1348C > T (Miro1 p.R450C) in the RHOT1 gene, were converted into induced pluripotent stem cells (iPSCs) using RNA-based and episomal reprogramming, respectively. The corresponding isogenic gene-corrected lines have been generated using CRISPR/Cas9 technology. These two isogenic pairs will be used to study Miro1-related molecular mechanisms underlying neurodegeneration in relevant iPSC-derived neuronal models (e.g., midbrain dopaminergic neurons and astrocytes).

引用

页数：6

共 24 条

[1] p Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson?s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p. T610A) in the RHOT1 gene encoding Miro1
Chemla, Axel
Arena, Giuseppe
Saraiva, Claudia
Berenguer-Escuder, Clara
Grossmann, Dajana
Grunewald, Anne
Klein, Christine
Seibler, Philip
Schwamborn, Jens C.
Kruger, Rejko
STEM CELL RESEARCH, 2023, 69
[2] Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
Gustavsson, Nadja
Marote, Ana
Pomeshchik, Yuriy
Russ, Kaspar
Azevedo, Carla
Chumarina, Margarita
Goldwurm, Stefano
Collin, Anna
Pinto, Luisa
Salgado, Antonio J.
Klementieva, Oxana
Roybon, Laurent
Savchenko, Ekaterina
STEM CELL RESEARCH, 2019, 34
[3] Generation and characterisation of seven induced pluripotent stem cell lines from two patients with Parkinson's disease carrying the pathological variant c.1087G>T of the LGR4 gene
Podvysotskaya, V. S.
Grigor'eva, E. V.
Malakhova, A. A.
Minina, J. M.
Vyatkin, Y. V.
Khabarova, E. A.
Rzaev, J. A.
Medvedev, S. P.
Kovalenko, L. V.
Zakian, S. M.
VAVILOVSKII ZHURNAL GENETIKI I SELEKTSII, 2025, 29 (01): : 15 - 25
[4] Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene
Sun, Xiaofang
Zhou, Xiang
Xiao, Xinhua
Chi, Jingwei
Dong, Bingzi
Wang, Yangang
STEM CELL RESEARCH, 2020, 45
[5] An induced pluripotent stem cell line (TRNDi009-C) from a Niemann-Pick disease type A patient carrying a heterozygous p.L302P (c.905 T > C) mutation in the SMPD1 gene
Baskfield, Amanda
Li, Rong
Beers, Jeanette
Zou, Jizhong
Liu, Chengyu
Zheng, Wei
STEM CELL RESEARCH, 2019, 38
[6] Generating a human induced pluripotent stem cell line (XACHi018-A) from a Timothy syndrome infant carrying heterozygous CACNA1C c.1216G>A > A (p.G406R) mutation
Jiang, Congshan
Huang, Wenjun
Zhou, Yafei
Wang, Jie
Lei, Hong
Niu, Youguo
Zhou, Rui
Zhang, Yanmin
STEM CELL RESEARCH, 2024, 80
[7] Generation of an induced pluripotent stem cell line (TRNDi030-A) from a patient with Farber disease carrying a homozygous p. Y36C (c. 107 A>G) mutation in ASAH1
Brooks, Brianna M.
Yeh, Charles D.
Beers, Jeanette
Liu, Chengyu
Cheng, Yu-Shan
Gorshkov, Kirill
Zou, Jizhong
Zheng, Wei
Chen, Catherine Z.
STEM CELL RESEARCH, 2021, 53
[8] Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T>A) mutation in JAGGED-1
Brooks, Brianna M.
Pradhan, Manisha
Cheng, Yu-Shan
Gorshkov, Kirill
Farkhondeh, Atena
Chen, Catherine Z.
Beers, Jeanette
Liu, Chengyu
Baumgaertel, Karsten
Rodems, Steven
Zheng, Wei
STEM CELL RESEARCH, 2021, 54
[9] Generation of two isogenic induced pluripotent stem cell lines from a 1-month-old nemaline myopathy patient harbouring a homozygous recessive c.121C > T (p.Arg39Ter) variant in the ACTA1 gene
Suleski, Isabella S.
Smith, Robert
Vo, Christina
Scriba, Carolin K.
Saker, Safaa
Larmonier, Thierry
Malfatti, Edoardo
Romero, Norma B.
Houweling, Peter J.
Nowak, Kristen J.
Laing, Nigel G.
Taylor, Rhonda L.
Clayton, Joshua S.
STEM CELL RESEARCH, 2022, 63
[10] Generation of induced pluripotent stem cell line LNDWCHi001-A from a patient with early-onset Parkinson's disease carrying the homozygous c.1898C > T (p. A633V) mutation in the PLA2G6 gene
Huang, Jingxuan
Jiang, Qirui
Pang, Dejiang
Yu, Yujiao
Cui, Yiyuan
Li, Chunyu
Shang, Huifang
STEM CELL RESEARCH, 2024, 75

← 1 2 3 →